er-176
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 14, 2014 (NCT02147392)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- er-176
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05805839 | Phase 2 | Jul 10, 2023 | Mayo Clinic |
| NCT04786223 | Phase 2 | Mar 30, 2021 | Mayo Clinic |
| NCT02147392 | Early Phase 1 (Phase 1) | May 14, 2014 | National Institute of Mental Health (NIMH) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 2 | 2 | 1 | 2021 |
| National Institute of Mental Health (NIMH) | Government | 1 | 1 | 1 | 2014 |
2 organizations
Page 1 / 1